Tranzyme Pharma Promotes David Moore to Chief Business Officer

Tranzyme Pharma Promotes David Moore to Chief Business Officer

[at noodls] – RESEARCH TRIANGLE PARK, N.C., Jan. 15, 2013 (GLOBE NEWSWIRE) — Tranzyme Pharma (Nasdaq:TZYM) today announced that David S. Moore has been named as Chief Business Officer….This is an abstract of the … more

View todays social media effects on OCRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Ocera is hiring next, click here to view

Share this post